Brain, Music & the Mozart Effect on Epilepsy
Dr. Zak Allal and Prof. Fabienne Picard on music therapy, Mozart's Sonata K.448, and the non-invasive stimulation of the epileptic brain
Source: YouTube , Journées Françaises de l'Épilepsie 2024, Session 1: Stimulation non invasive du cerveau épileptique. Talk delivered in French.
About this Talk
Presented at the Journées Françaises de l'Épilepsie 2024 in the opening session on non-invasive stimulation of the epileptic brain, this 22-minute duo presentation pairs Dr. Zak Allal with Prof. Fabienne Picard, neurologist at the University Hospitals of Geneva. Together they examine a question the conference organizers called "Can music stimulate the epileptic brain?"
The talk is built in two halves. Zak Allal opens with a map of the field, what music therapy research actually looks like today and what neuroscience knows about how the brain processes music. Fabienne Picard follows with the clinical evidence specific to epilepsy, walking through the randomized controlled trials that have tested Mozart's Sonata K.448 as a non-pharmacological intervention.
Part 1, Brain & Music (Zak Allal)
The state of music therapy research
Bibliometric analysis shows music therapy publications have quadrupled in twenty years, led by the United States and Germany. Dominant keywords include anxiety, depression, pain, dementia, and palliative care, but epilepsy is strikingly absent from the top of the list, which is part of what makes this session unusual.
Clinical and financial impact
Zak reviews measured effects of music therapy across stroke, Parkinson's disease, traumatic brain injury, multiple sclerosis, oncology, and palliative care. He also highlights a neonatal intensive care study at the University Hospitals of Geneva showing accelerated maturation of emotion-processing cortical areas in premature infants, and a U.S. example where music therapy shortened NICU stays by two weeks, equivalent to roughly $42,000 saved per child.
How the brain processes music
There is no single "music center" in the brain. Different regions handle pitch, harmony, rhythm, familiarity, and emotional response, and they synchronize across the auditory, memory, and reward networks, including the amygdala. A short audio excerpt of Mozart's Sonata K.448 is played live, and Zak notes that structural rhythm, not melodic pitch, seems to be the active ingredient behind the cognitive effects attributed to it.
Beyond Mozart: Bach and memory
Zak points to research suggesting Bach's rigidly structured harmonies make his music an unusually good tool for studying memory, often more useful than numerical or text-based stimuli.
Part 2, The Mozart Effect & Epilepsy (Prof. Fabienne Picard)
Taiwanese RCT in children
A 2014 randomized controlled trial in 48 children after a first unprovoked seizure. Children who listened to Sonata K.448 nightly for six months had seizure recurrence in 36% of cases versus 75% in the control group, alongside an 80% reduction in epileptiform EEG abnormalities that held steady through six months of follow-up.
South Carolina three-year trial
A three-year study in patients with neurological disability and epilepsy using overnight passive exposure to K.448 in 8.5-minute cycles. The music did not disrupt sleep, and the treatment phase showed a significant 24% reduction in seizures versus control, with a further 33% reduction the year after and complete seizure freedom in 24% of patients.
Canadian crossover trial in drug-resistant epilepsy
A 13-patient crossover study comparing daily K.448 against a spectrally matched but structurally scrambled control. Seizure frequency dropped in every patient but one, with an overall mean reduction of 35%, and one participant remained seizure-free for the entire nine-month observation window.
Supporting EEG evidence
Picard walks through supporting studies: a 1998 paper by Hughes showing EEG effects after just five minutes of listening; a stereo-EEG study in Barbara Jobst's team finding interictal spike reductions of up to 66% after 60 seconds of K.448, with Wagner's Lohengrin producing no such effect; and a pediatric trial in 26 children showing reduced interictal spikes in 67% of the music group versus 42% of controls.
Why would this work?
Two main hypotheses: first, resonance between specific temporal and harmonic patterns in the music and ongoing neural oscillations, yielding an anti-epileptogenic effect; second, and more frequently invoked, activation of the parasympathetic nervous system, supported by ECG and heart-rate-variability data from the Taiwanese cohort. Picard also mentions a separate stereo-EEG study where a simple 40 Hz tone reduced interictal spikes by 35% in four patients, possibly via GABAergic interneuron activation.
Criticisms and the MELODIE trial
A Viennese meta-analysis has pushed back, citing inconsistent results, small populations, and limited access to primary data. Picard acknowledges the critique and ends by announcing a planned French multicenter PHRC trial, the MELODIE study, coordinated by Fabrice Bartolomei across 26 French centers, designed to settle the question with a properly powered three-arm design comparing K.448, a similar-structure piece, and a distinctly different control music.